Management of Prostate Cancer Using Hand Healing: A Brief Case Study

Diagnosis

On 12 September 2008 the patient was diagnosed with prostate cancer at Tokyo Medical and Dental University. The patient received multiple blood tests though no biopsies were provided. The patient began hormone treatment but was not admitted to hospital.

Method and Treatment

Female hormone administered (the term of effect from 1 to 3 months).

The patient stopped receiving the administered female hormones on 16 April 2016, and began healing therapy three months later. Receiving only healing therapy for 5 months (on 20 February 2016) the patient received a PSA (Prostate-specific antigen) test.

The patient underwent a course of hand healing through a technique developed by Dr Tomita. This method is based on Reverend Rosalyn L Bruyere of the Healing Light Center Church’s whole-body technique of Chelation. The process involves the rebalancing of chakra to create stability in the electromagnetic fields. Energy is moved up the patient’s body from the feet, through the major chakra system, to the crown chakra.

Results

According to the PSA test, the level of PSA had risen by 0.08 over the whole period not receiving hormone therapy. This is a far slower rate of increase than would be expected and indicates no immediate need for invasive procedures. However, instead of performing a biopsy for further inspection, the doctor presented a misleading logarithmic graph and urged for a prostatectomy.

While continuing healing treatment only, the patient’s PSA remained safely within normal levels. Upon discontinuing the healing course the patient’s PSA was at 0.11. PSA levels under 4.0 are considered normal.

Despite the far lower than average alterations in PSA level, the patient discontinued his healing course on 22 April, 2016 and did not report to the healing clinic whether he proceeded with the operation or not.

Conclusion

This case study indicates an effect of healing on the condition of the prostate. In particular an effect on PSA count during prostate cancer. Alterations to PSA count were kept steadily within normal levels for a period of ten months, whereas PSA without hormone treatment would usually be expected to raise above normal level within 3-5 months. The patient was recommended medical treatment without receiving a biopsy, which would have shown changes in the cancer more clearly.